[
  {
    "ts": null,
    "headline": "Molina to Report Q2 Earnings: Healthy Revenues, Weak Pulse on Earnings",
    "summary": "MOH's Q2 revenues are set to rise nearly 10%, but rising costs cloud its profit outlook.",
    "url": "https://finnhub.io/api/news?id=7e425f1647e4d45445e854a79d68d35beff6b6d5f5f4a1108b9ebe3308173ee0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752854580,
      "headline": "Molina to Report Q2 Earnings: Healthy Revenues, Weak Pulse on Earnings",
      "id": 136007914,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "MOH's Q2 revenues are set to rise nearly 10%, but rising costs cloud its profit outlook.",
      "url": "https://finnhub.io/api/news?id=7e425f1647e4d45445e854a79d68d35beff6b6d5f5f4a1108b9ebe3308173ee0"
    }
  },
  {
    "ts": null,
    "headline": "Good Neighbor Pharmacy Celebrates Independent Community Pharmacy Excellence at ThoughtSpot 2025",
    "summary": "CONSHOHOCKEN, Pa., July 18, 2025--Good Neighbor Pharmacy, a national franchise for independent pharmacies offered through Cencora, brought together more than 4,000 community pharmacy owners, industry experts and partners for its flagship annual tradeshow and conference, ThoughtSpot. Now in its 14th year, ThoughtSpot serves as a celebration of Good Neighbor Pharmacy and its member pharmacies, recognizing their unwavering commitment to improving community health and advancing the future of pharmac",
    "url": "https://finnhub.io/api/news?id=46975f2a8cd234e89694accad1a249033c4d26a3b1d382d8f93d91420acf93a5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752854400,
      "headline": "Good Neighbor Pharmacy Celebrates Independent Community Pharmacy Excellence at ThoughtSpot 2025",
      "id": 136006063,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "CONSHOHOCKEN, Pa., July 18, 2025--Good Neighbor Pharmacy, a national franchise for independent pharmacies offered through Cencora, brought together more than 4,000 community pharmacy owners, industry experts and partners for its flagship annual tradeshow and conference, ThoughtSpot. Now in its 14th year, ThoughtSpot serves as a celebration of Good Neighbor Pharmacy and its member pharmacies, recognizing their unwavering commitment to improving community health and advancing the future of pharmac",
      "url": "https://finnhub.io/api/news?id=46975f2a8cd234e89694accad1a249033c4d26a3b1d382d8f93d91420acf93a5"
    }
  },
  {
    "ts": null,
    "headline": "Danaher Gears Up to Post Q2 Earnings: What Lies Ahead for the Stock?",
    "summary": "DHR's Q2 results are likely to reflect Life Sciences weakness, but strength in Biotechnology & Diagnostics units and Abcam acquisition add upside potential.",
    "url": "https://finnhub.io/api/news?id=659db87a18308be51bdb1c4691bb5b7140ba7805ceb4655739300e20031fffac",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752852360,
      "headline": "Danaher Gears Up to Post Q2 Earnings: What Lies Ahead for the Stock?",
      "id": 136007923,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "DHR's Q2 results are likely to reflect Life Sciences weakness, but strength in Biotechnology & Diagnostics units and Abcam acquisition add upside potential.",
      "url": "https://finnhub.io/api/news?id=659db87a18308be51bdb1c4691bb5b7140ba7805ceb4655739300e20031fffac"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why You Should Hold Accuray Stock in Your Portfolio for Now",
    "summary": "ARAY rides strong global demand and CyberKnife momentum, but order declines and backlog pressure temper the outlook.",
    "url": "https://finnhub.io/api/news?id=3c3091a28cb96c0c472f5692be811b28cc3d1a62f1d6e81757062ed30fa45034",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752848760,
      "headline": "Here's Why You Should Hold Accuray Stock in Your Portfolio for Now",
      "id": 136006857,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "ARAY rides strong global demand and CyberKnife momentum, but order declines and backlog pressure temper the outlook.",
      "url": "https://finnhub.io/api/news?id=3c3091a28cb96c0c472f5692be811b28cc3d1a62f1d6e81757062ed30fa45034"
    }
  },
  {
    "ts": null,
    "headline": "TMO to Report Q2 Earnings: Analytical Instruments Segment in Focus",
    "summary": "Thermo Fisher eyes second-quarter 2025 growth with new tech launches in Analytical Instruments and Life-Science Solutions segments.",
    "url": "https://finnhub.io/api/news?id=67bc7bec0748659333bc380cbcecb56dd9dc0d4884eb389b985c4d1c9302a45d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752842100,
      "headline": "TMO to Report Q2 Earnings: Analytical Instruments Segment in Focus",
      "id": 136005746,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Thermo Fisher eyes second-quarter 2025 growth with new tech launches in Analytical Instruments and Life-Science Solutions segments.",
      "url": "https://finnhub.io/api/news?id=67bc7bec0748659333bc380cbcecb56dd9dc0d4884eb389b985c4d1c9302a45d"
    }
  },
  {
    "ts": null,
    "headline": "Should You Add Edwards Lifesciences Stock to Your Portfolio Now?",
    "summary": "EW gains traction with surgical tech and TAVR growth, but macro pressures and FX headwinds weigh on margins.",
    "url": "https://finnhub.io/api/news?id=00bae9114789a2033aa330af7445ce9c65720ff19e986d5d36e112647b6f7d7c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752841620,
      "headline": "Should You Add Edwards Lifesciences Stock to Your Portfolio Now?",
      "id": 136006065,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "EW gains traction with surgical tech and TAVR growth, but macro pressures and FX headwinds weigh on margins.",
      "url": "https://finnhub.io/api/news?id=00bae9114789a2033aa330af7445ce9c65720ff19e986d5d36e112647b6f7d7c"
    }
  }
]